Rephonic
Artwork for Journal of Clinical Oncology

Journal of Clinical Oncology (JCO) Podcast

American Society of Clinical Oncology (ASCO)
Breast Cancer
Non-Small Cell Lung Cancer
Overall Survival
Clinical Trials
Immunotherapy
Oncology
Pembrolizumab
Chemotherapy
Just ASK Initiative
ASCO
Endometrial Cancer
Progression-Free Survival
Bevacizumab
Muscle Invasive Bladder Cancer
Gastric Cancer
Prostate Cancer
Smoking Cessation
Cancer Survivorship
Rituximab
Smoking Assessment

The Journal of Clinical Oncology Podcast presents analyses and discussions centered on the latest findings published in ASCO's flagship Journal of Clinical Oncology. Host Dr. Davide Soldato facilitates interviews and scholarly discourse on the most impactful published findings. The Journal of Clinical Oncology Podcast is the trusted resource that empowers you to integrate cutting-edge evidence int... more

PublishesTwice monthlyEpisodes470Founded16 years ago
Number of ListenersCategories
MedicineHealth & Fitness

Listen to this Podcast

Artwork for Journal of Clinical Oncology

Latest Episodes

Host Dr. Jake New interviews Dr. Alexander Sherry and Dr. Chad Tang about their JCO article, "Addition of Metastasis-Directed Therapy to Standard of Care for Oligometastatic Disease: Primary Aggregated Analysis of All Baskets From the Phase II Random... more

YouTube

What long-term outcomes can be achieved with neoadjuvant cemiplimab, and how does immunotherapy reshape the treatment landscape for advanced cutaneous squamous cell carcinoma? Host Dr. Davide Soldato interviews Dr. Neil Gross on his simultaneous publ... more

YouTube

What pCR rates can be achieved with neoadjuvant THP, and which patients are most likely to respond? Host Dr. Davide Soldato interviews Dr. Nadine Tung on her article, "Pathologic Complete Response (pCR) Rate and Predictors of Response to Taxane, Tras... more

YouTube

Host Dr. Jake New interviews Dr. Makoto Tahara about the JCO article "Long-Term Follow-Up of JCOG1008, a Randomized Phase II/III Trial of Chemoradiotherapy Comparing 3-Weekly Cisplatin With Weekly Cisplatin in Postoperative Head and Neck Cancer." The... more

YouTube

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

ASCO Daily News
ASCO Daily NewsAmerican Society of Clinical Oncology (ASCO)
Two Onc Docs
Two Onc DocsSam and Karine
ASCO Education
ASCO EducationAmerican Society of Clinical Oncology (ASCO)
ASCO Guidelines
ASCO GuidelinesAmerican Society of Clinical Oncology (ASCO)
NEJM This Week
NEJM This WeekNEJM Group

Recent Guests

Alexander Sherry
Radiation oncologist and assistant professor
Mayo Clinic
Episode: JCO Article Insights: Metastasis-Directed Therapy for Oligometastatic Solid Tumors
Chad Tang
Radiation oncologist in the Department of Genitourinary Radiation Oncology
MD Anderson Cancer Center
Episode: JCO Article Insights: Metastasis-Directed Therapy for Oligometastatic Solid Tumors
Neil Gross
Director of Clinical Research in Head and Neck Surgery at MD Anderson Cancer Center
MD Anderson Cancer Center
Episode: JCO at ESMO 2026: Phase 2 Neoadjuvant Cemiplimab in CSCC: Final Analysis
Dr. Nadine Tung
JCO author
Harvard Medical School; Beth Israel Deaconess Medical Center
Episode: pCR Rates and Predictors With THP in HER2-Positive Breast Cancer: EA1181/CompassHER2 pCR
Dr. Tahara
Author of JCOG1008 long-term follow-up study
JCOG / Japan
Episode: JCO Article Insights: Long-Term Follow-Up of Weekly Cisplatin + RT in Postoperative HNC
Erin Mobley
Assistant Professor in the Division of General Surgery and Surgical Oncology at the University of Florida
University of Florida College of Medicine
Episode: Dexrazoxane and Long-Term Cardiac Function After Doxorubicin: Insights From COG ALTE11C2
Eric Chow
Pediatric Oncologist and Co-Director of the Survivorship Program
Fred Hutchinson Cancer Center; University of Washington
Episode: Dexrazoxane and Long-Term Cardiac Function After Doxorubicin: Insights From COG ALTE11C2
Vedang Murthy
Professor and Radiation Oncologist
Tata Memorial Center, Mumbai, India
Episode: Bladder Adjuvant RadioTherapy (BART) RCT for High Risk MIBC
Elise Park
Professor of Psychiatry and Medicine at Harvard Medical School and Mass General Brigham Cancer Institute
Harvard Medical School; Mass General Brigham Cancer Institute
Episode: Effectiveness of a Virtual Tobacco Treatment for Cancer Patients

Hosts

Davide Soldato
Medical oncologist at Ospedale San Martino in Genoa
Jake New
Medical oncologist at Scripps Health

Reviews

4.2 out of 5 stars from 90 ratings
  • Good choice of journal publications

    Good information being presented and well thought out interviews with authors.

    Apple Podcasts
    5
    Clinical26
    United States5 months ago
  • Good Information, but

    The information provided is important, but the presenters are stilted.

    Apple Podcasts
    4
    Jtn2
    United States10 years ago
  • I really want to like this podcast, but...

    unfortunately, although the content is excellent, the delivery is awful. Most of the time the presenters just read the text of the podcast - very fast, in a monotonous voice. While as a written piece it could perhaps work, it doesn't work as an audio. I end up pausing and rewinding, and eventually giving up on learning and remembering. An audio lecture needs to be delivered at a slower pace, with fewer lists and numbers...

    Apple Podcasts
    2
    Zoirusha
    United States14 years ago
  • Nice

    Good platform

    Apple Podcasts
    5
    Gazelle73
    United States15 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Reviews praise the information and the platform, while feedback on presentation is mixed.
One listener says the fast pace and dense lists of details make episodes difficult to follow by audio.
Some listeners find the presenters' delivery stilted or monotonous.
Listeners value the focus on important journal publications and the quality of interviews with study authors.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

JCO at ESMO 2026: Phase 2 Neoadjuvant Cemiplimab in CSCC: Final Analysis
Q: What do the long-term outcomes suggest about further treatment after a complete pathological response?
At a median follow-up of 54 months, patients with a complete pathological response had excellent outcomes with no recurrences in that group. Gross said the findings support omitting adjuvant treatment for such patients in the trial, while noting that pathological response was centrally reviewed and patients underwent surgery.
JCO at ESMO 2026: Phase 2 Neoadjuvant Cemiplimab in CSCC: Final Analysis
Q: Why was neoadjuvant immunotherapy considered for this patient population, and what was the study design?
Gross explained that surgery and radiation can cause substantial functional and quality-of-life effects, particularly for head and neck tumors. The phase 2 trial tested up to four doses of neoadjuvant cemiplimab, with treatment decisions after surgery left to investigators.
JCO Article Insights: Metastasis-Directed Therapy for Oligometastatic Solid Tumors
Q: Are we ready to use circulating tumor DNA to recommend or withhold treatment, or what would need to be demonstrated before we use it in such a way?
Sherry says circulating tumor DNA was an exploratory measure and was not used to guide trial management. Randomized studies must show that using the test changes management and improves patient outcomes before it can direct treatment.
JCO Article Insights: Metastasis-Directed Therapy for Oligometastatic Solid Tumors
Q: Could you briefly explain why you chose a histology-specific basket design and what that has taught us beyond just an overall pooled result?
Tang explains that the trial treated oligometastatic disease as the shared feature across histologies, then examined whether metastasis-directed therapy had different effects in separate cancer-type baskets.
pCR Rates and Predictors With THP in HER2-Positive Breast Cancer: EA1181/CompassHER2 pCR
Q: Why not run a randomized phase III trial, and what was the design choice here?
A randomized trial comparing outcomes after achieving pathologic complete response with different regimens would require an enormous sample due to already excellent outcomes, so the team used a single-arm approach informed by prior data to test whether PCR with THP could translate into comparable outcomes.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Journal of Clinical Oncology

What is Journal of Clinical Oncology about and what kind of topics does it cover?

Evidence-focused conversations examine clinical oncology research published in a major medical journal, with particular attention to trial design, results, limitations, and implications for patient care. Regular host Davide Soldato and contributing physician hosts interview study authors, senior editors, and clinical specialists, often drawing out how findings compare with existing treatment approaches and what evidence is still needed before practice changes.

Topics span solid tumors, hematologic cancers, cancer prevention, survivorship, and supportive care, with recurring attention to immunotherapy, targeted treatment, biomarkers, and personalized care. The format is scholarly and specific, making it a strong fit for oncology professiona... more

Where can I find podcast stats for Journal of Clinical Oncology?

Rephonic provides a wide range of podcast stats for Journal of Clinical Oncology. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Journal of Clinical Oncology and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Journal of Clinical Oncology get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for Journal of Clinical Oncology, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Journal of Clinical Oncology?

Rephonic provides comprehensive predictive audience data for Journal of Clinical Oncology, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Journal of Clinical Oncology have?

To see how many followers or subscribers Journal of Clinical Oncology has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Journal of Clinical Oncology?

These podcasts share a similar audience with Journal of Clinical Oncology:

1. ASCO Daily News
2. Two Onc Docs
3. ASCO Education
4. ASCO Guidelines
5. NEJM This Week

How many episodes of Journal of Clinical Oncology are there?

Journal of Clinical Oncology launched 16 years ago and published 470 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Journal of Clinical Oncology?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Journal of Clinical Oncology?

Rephonic pulls ratings and reviews for Journal of Clinical Oncology from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Journal of Clinical Oncology?

Rephonic provides full transcripts for episodes of Journal of Clinical Oncology. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Journal of Clinical Oncology?

Recent guests on Journal of Clinical Oncology include:

1. Alexander Sherry
2. Chad Tang
3. Neil Gross
4. Dr. Nadine Tung
5. Dr. Tahara
6. Erin Mobley
7. Eric Chow
8. Vedang Murthy

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days